FDA turns down ViiV Healthcare’s injectable HIV drug
In an announcement over the weekend, the British drugmaker said the FDA had cited manufacturing issues in its complete response letter for cabotegravir and rilpivirine.
rilpivirine
In an announcement over the weekend, the British drugmaker said the FDA had cited manufacturing issues in its complete response letter for cabotegravir and rilpivirine.